Indivior Pharmaceuticals (INDV) Other Working Capital Changes (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Other Working Capital Changes of $18.0 million for Q1 2026, little changed year-over-year from $18.0 million in Q1 2025, and up 263.64% quarter-over-quarter from -$11.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at $18.0 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes changed 0.0% year-over-year to $18.0 million; the TTM figure through Mar 2026 stood at -$49.0 million (down 232.43% YoY), while the FY2025 annual figure was -$49.0 million, up 87.0% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $18.0 million, up from -$11.0 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $18.0 million in Q1 2025, with the low at -$396.0 million in Q1 2024.
- The 3-year median for Other Working Capital Changes is $3.0 million (2024), against an average of -$45.3 million.
- Peak annual rise in Other Working Capital Changes reached 104.55% in 2025, while the deepest fall reached 1733.33% in 2025.
- Indivior Pharmaceuticals' Other Working Capital Changes stood at $12.0 million in 2024, then tumbled by 191.67% to -$11.0 million in 2025, then soared by 263.64% to $18.0 million in 2026.
- Business Quant data shows INDV's Other Working Capital Changes at $18.0 million in Q1 2026, -$11.0 million in Q4 2025, and -$7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.52 Bn | 4.30 Bn | 294.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.00 Mn |
| Jun 30, 2026 | 17.00 Mn |
| Jun 30, 2026 | 17.00 Mn |
| Mar 31, 2026 | 18.00 Mn |
| Mar 31, 2026 | 18.00 Mn |
| Mar 31, 2026 | 18.00 Mn |
| Dec 31, 2025 | -11.00 Mn |
| Dec 31, 2025 | -11.00 Mn |
| Dec 31, 2025 | -11.00 Mn |
| Sep 30, 2025 | -7.00 Mn |
| Sep 30, 2025 | -7.00 Mn |
| Sep 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -49.00 Mn |
| Jun 30, 2025 | -49.00 Mn |
| Jun 30, 2025 | -49.00 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Mar 31, 2025 | 18.00 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Dec 31, 2024 | 12.00 Mn |